Last reviewed · How we verify
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine is a Small molecule drug developed by University of Missouri-Columbia. It is currently in Phase 1 development. Also known as: Exparel.
At a glance
| Generic name | Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine |
|---|---|
| Also known as | Exparel |
| Sponsor | University of Missouri-Columbia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block (NA)
- Prospective Evaluation of Efficacy of Tumescent Steroid Infiltration in Mandibular Third Molar Surgery: a Split Mouth Randomized Study (NA)
- Spinal Anesthesia For Enhanced Recovery After Liver Surgery (NA)
- Lidocaine Versus Bupivacaine in Orthognathic Surgery (PHASE4)
- Effect of Three Different Postcesarean Analgesic Techniques on QbsQor-10 Score (NA)
- Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty (PHASE3)
- Carpal Tunnel Release Under Local Anaesthesia With or Without Distal Median Nerve Block (NA)
- aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine CI brief — competitive landscape report
- Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine updates RSS · CI watch RSS
- University of Missouri-Columbia portfolio CI
Frequently asked questions about Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine
What is Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine?
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine is a Small molecule drug developed by University of Missouri-Columbia.
Who makes Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine?
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine is developed by University of Missouri-Columbia (see full University of Missouri-Columbia pipeline at /company/university-of-missouri-columbia).
Is Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine also known as anything else?
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine is also known as Exparel.
What development phase is Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine in?
Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine is in Phase 1.
Related
- Manufacturer: University of Missouri-Columbia — full pipeline
- Also known as: Exparel
- Compare: Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine vs similar drugs
- Pricing: Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine cost, discount & access